Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jan-Feb;37(1):17-20.
doi: 10.1016/j.bjhh.2014.07.006. Epub 2014 Jul 18.

Diversity of breakpoints of variant Philadelphia chromosomes in chronic myeloid leukemia in Brazilian patients

Maria de Lourdes Lopes Ferrari Chauffaille  1 , Ana Carolina de Almeida Bandeira  2 , Aline Schiavoni Guarnieri da Silva  3
Affiliations

Diversity of breakpoints of variant Philadelphia chromosomes in chronic myeloid leukemia in Brazilian patients

Maria de Lourdes Lopes Ferrari Chauffaille et al. Rev Bras Hematol Hemoter. 2015 Jan-Feb.

Abstract

Background: Chronic myeloid leukemia is a myeloproliferative disorder characterized by the Philadelphia chromosome or t(9;22)(q34.1;q11.2), resulting in the break-point cluster region-Abelson tyrosine kinase fusion gene, which encodes a constitutively active tyrosine kinase protein. The Philadelphia chromosome is detected by karyotyping in around 90% of chronic myeloid leukemia patients, but 5-10% may have variant types. Variant Philadelphia chromosomes are characterized by the involvement of another chromosome in addition to chromosome 9 or 22. It can be a simple type of variant when one other chromosome is involved, or complex, in which two or more chromosomes take part in the translocation. Few studies have reported the incidence of variant Philadelphia chromosomes or the breakpoints involved among Brazilian chronic myeloid leukemia patients.

Objective: The aim of this report is to describe the diversity of the variant Philadelphia chromosomes found and highlight some interesting breakpoint candidates for further studies.

Methods: the Cytogenetics Section Database was searched for all cases with diagnoses of chronic myeloid leukemia during a 12-year period and all the variant Philadelphia chromosomes were listed.

Results: Fifty (5.17%) cases out of 1071 Philadelphia-positive chronic myeloid leukemia were variants. The most frequently involved chromosome was 17, followed by chromosomes: 1, 20, 6, 11, 2, 10, 12 and 15.

Conclusion: Among all the breakpoints seen in this survey, six had previously been described: 11p15, 14q32, 15q11.2, 16p13.1, 17p13 and 17q21. The fact that some regions get more frequently involved in such rare rearrangements calls attention to possible predisposition that should be further studied. Nevertheless, the pathological implication of these variants remains unclear.

Keywords: Brazil; Chromosome breakpoints; Leukemia, myelogenous, chronic, BCR-ABL positive; Oncogenes; Philadelphia chromosome.

PubMed Disclaimer

References

    1. Swerdlow S.H., Campo E., Harris N.L., Jaffe E.S., Pileri S.A., Stein H. 4th ed. IARC; Lyon: 2008. WHO Classification of tumors of haematopoietic and lymphoid tissues; p. 439.
    1. Baccarani M., Deininger M.W., Rosti G., Hochhaus A., Soverini S., Apperley J.F. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013. Blood. 2013;122(6):871–884. - PMC - PubMed
    1. Ishihara T., Minamihisamatsu M. The Philadelphia chromosome. Considerations based on studies of variant Ph translocations. Cancer Genet Cytogenet. 1988;32(1):75–92. - PubMed
    1. Fisher A.M., Strike P., Scott C., Moorman A.V. Breakpoints of variant 9;22 translocations in CML locate preferentially in the CG-richest regions of the genome. Genes Chromosomes Cancer. 2005;43(4):383–389. - PubMed
    1. Marzocchi G., Castagenetti F., Luatti S., Baldazzi C., Stacchini M., Gugliotta G. Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis. Blood. 2011;117(25):6793–6800. - PubMed

LinkOut - more resources